GARP expressed on HSCs drives the development of liver fibrosis via cell contraction‐mediated activation of latent TGF‐β, suggesting GARP as a novel target for the treatment of fibrotic disease.160. The gene discussed is TGFB1; the disease is Hepatic fibrosis.